Here are some publications from the website's author:

 

Lawrie C.H. MicroRNA expression in erythropoiesis and erythroid disorders. Br J Haematol. 2009 Nov 12.

Lawrie, C.H., Dyar, O.J., Jones, M., Ventura , R., Chi, J., Tramonti, D., Pezzella, F., Boultwood, J., Wainscoat, J.S., Schuh, A., Hatton, C.S.R. MicroRNA expression in chronic lymphocytic leukaemia. Br J Haematol . 2009 Aug 13.

Lawrie, C.H., Chi, J., Tramonti, D., Ballabio, E., Taylor , S., Saunders , N.J. , Palazzo, S., Pezzella, F., Boultwood, J., Wainscoat, J.S. and Hatton, C.S.R. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. J Cell Mol Med . 2009 Jul;13(7):1248-60.

Lawrie, C.H ., Cooper, C.D., Ballabio, E., Chi, J., Tramonti, D., Hatton, C.S.R. Aberrant expression of microRNA biosynthetic pathway components is a common feature of haematological malignancy. Br J Haematol . 2009 May;145(4):545-8.

Yao , Y., Smith, L.P., Y. Zhao, Lawrie, C.H., Watson, M., Nair, V. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J Gen Virol . 2009 Jul;90(Pt 7):1551-9.

Lawrie CH, Shilling R, Troussard X, Cattan H, Mossafa H, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS. Expression profiling of persistent polyclonal B-cell lymphocytosis suggests constitutive expression of the AP-1 transcription complex and downregulation of Fas-apoptotic and TGFbeta signalling pathways. Leukemia . 2009 Mar;23(3):581-3.

Lawrie CH. microRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? J Cell Mol Med. Sep-Oct;12(5A):1432-44.

Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol . 2008 May; 141 ( 5 ): 672-5 .

Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, Watson M, Nair V. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J Virol . 2008 Apr; 82 ( 8 ): 4007-15 .

Lawrie CH, Saunders NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CD, Brown PJ, Troussard X, Mossafa H, Enver T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS. MicroRNA expression in lymphocyte development and malignancy. Leukemia. 2008 Jul; 22(7):1440-6.

Lawrie CH. MicroRNA expression in lymphoma. Expert Opin Biol Ther. 2007 Sep;7(9):1363-74.

Lawrie CH. MicroRNAs and haematology: small molecules, big function.Br J Haematol. 2007 Jun;137(6):503-12.

Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, Wainscoat JS, Hatton CS. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007 Sep 1;121(5):1156-61.

Boultwood J, Pellagatti A, Cattan H, Lawrie CH, Giagounidis A, Malcovati L, Porta MG, Jädersten M, Killick S, Fidler C, Cazzola M, Hellström-Lindberg E, Wainscoat JS. Gene expression profiling of CD34(+) cells in patients with the 5q- syndrome.
Br J Haematol. 2007 Nov;139(4):578-89.

Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, Sewer A, Zavolan M, Nair V. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation to those encoded by MDV-1. J Virol. 2007 Jul;81(13):7164-70.